Proxalutamide shows promise as potential COVID-19 treatment
At the outset of the COVID pandemic, men appeared to suffer higher rates of severe illness and death, leading researchers ...
At the outset of the COVID pandemic, men appeared to suffer higher rates of severe illness and death, leading researchers ...
In a recent pre-print uploaded to the medRxiv server, researchers inoculated 34 healthy volunteers with a pre-Alpha severe acute respiratory ...
In a recent study posted to the bioRxiv* preprint server, researchers at Emory University used severe acute respiratory syndrome coronavirus ...
The COVID-19 pandemic has led to an explosion of clinical research resulting in the development of a variety of vaccines ...
In a recent review published in the Journal of Ginseng Research, researchers discussed the therapeutic potential of Panax ginseng for ...
The antibody drugs sotrovimab and casirivimab-imdevimab are not recommended for patients with covid-19, says a WHO Guideline Development Group of ...
In a recent study published in the Annals of Internal Medicine, researchers assessed the correlation between severe acute respiratory syndrome ...
In a recent study posted to the bioRxiv* preprint server, researchers introduced a phenotypic screening assay for identifying compounds with ...
In a recent study posted to the bioRxiv* pre-print server, researchers evaluated the activity of nitazoxanide against human coronaviruses (HCoVs). ...
A monoclonal antibody treatment taken by patients hospitalized with COVID-19 did not improve recovery time but did reduce deaths, according ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: [email protected]
© 2023 Sepoy.net